Three-D ultrasound designed for cardiac imaging may be just what interventionalists need to improve the administration of nerve blocks, according to researchers at the Mayo Clinic in Jacksonville, FL.
Three-D ultrasound designed for cardiac imaging may be just what interventionalists need to improve the administration of nerve blocks, according to researchers at the Mayo Clinic in Jacksonville, FL.
Anesthesiologists Neil Feinglass and Steven Clendenen have adapted a Philips iU22 echocardiography system and cardiac probes to visualize nerves so as to better administer local anesthesia. The 3D images help guide needles to nerve endings, such as those exiting the cervical spine.
Nerve blocks can reduce the time needed for interventions, helping such procedures run more efficiently and sparing patients the effects of general anesthesia, Clendenen said. But nerve blocks are difficult to administer, even with 2D ultrasound.
"The problem with 2D is finding the tip of the needle," Clendenen said. "You have to manipulate the probe and jiggle the needle to find it. With 3D ultrasound, you manipulate the image."
Clendenen has discussed with Philips executives how its technology might be tailored for anesthesiology. One idea is to develop a system with presets optimized for nerve imaging. This would include removing echo features. Another idea is to boost the frequency from 7 MHz to 9 MHz to improve resolution in the near field and to expand the width of the probe for more coverage.
In the meantime, Clendenen and Feinglass are making do with off-the-shelf equipment. They have had their best results using an x7-2 Matrix array, which Philips designed to image infant hearts. The resolution with this probe is good enough to actually see the nerve roots, Clendenen said, compared with 2D imaging, which produces little more than longitudinal dots indicating the presence of nerves.
The Mayo physicians have used the 3D technique to place blocks on nerves in the neck, under arms, below collarbones, and in the back upper portion of legs. Such regional blocks exert less stress on patients' hearts. This promotes recovery and improved rehabilitation, Clendenen said. Through detailed guidance, a miniature catheter can be placed alongside the nerves, allowing for at-home administration of anesthetic.
"We can send people home the day of or day after surgery instead of keeping them in the hospital with a morphine infusion," he said. "It is cutting-edge technology."
MRI or Ultrasound for Evaluating Pelvic Endometriosis?: Seven Takeaways from a New Literature Review
September 13th 2024While noting the strength of MRI for complete staging of disease and ultrasound’s ability to provide local disease characterization, the authors of a new literature review suggest the two modalities offer comparable results for diagnosing pelvic endometriosis.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
FDA Clears Controlled Contrast Delivery Method for Ultrasound Imaging of Fallopian Tubes
September 9th 2024Facilitating natural contrast delivery through an intrauterine catheter, FemChec can be utilized for ultrasound assessment of fallopian tubes and may provide diagnostic confirmation for an emerging non-surgical option for permanent birth control.
FDA Clears Emerging Cardiovascular Point-of-Care Ultrasound Platform
August 22nd 2024Combining four CAD modules for valvular pathologies with a variety of automated measurements, the AI-enabled AISAP Cardio ultrasound system reportedly facilitates up to a 90 percent accuracy rate in detecting common cardiac conditions.
Predicting DCIS Upgrade to Invasive Breast Cancer: Can Contrast-Enhanced Ultrasound Have an Impact?
August 21st 2024Adding two key findings from contrast-enhanced ultrasound to a predictive model of mammography, conventional ultrasound and clinicopathological findings led to a 86.1 percent AUROC for predicting the upgrading of ductal carcinoma in situ to invasive breast cancer, according to new research.